中国神经再生研究（英文版）2019，Vol.14Issue(5)：745-748,4.DOI:10.4103/1673-5374.249217
Repositioning of dipeptidyl peptidase-4 inhibitors and glucagon like peptide-1 agonists as potential neuroprotective agents
Repositioning of dipeptidyl peptidase-4 inhibitors and glucagon like peptide-1 agonists as potential neuroprotective agents
Shaker A. Mousa 1Bassam M. Ayoub2
作者信息
- 1. Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, USA 2 The Center for Drug Research and Development (CDRD), Pharmaceutical Chemistry Department, Faculty of Pharmacy, The British University in Egypt, El-Sherouk city, Cairo, Egypt
- 折叠
摘要
关键词
repositioning/DPP-4 inhibitors/GLP-1RA/neural regeneration/blood-brain barrier/Parkinson’s disease/Alzheimer’s disease/diabetic retinopathyKey words
repositioning/DPP-4 inhibitors/GLP-1RA/neural regeneration/blood-brain barrier/Parkinson’s disease/Alzheimer’s disease/diabetic retinopathy引用本文复制引用
Shaker A. Mousa,Bassam M. Ayoub..Repositioning of dipeptidyl peptidase-4 inhibitors and glucagon like peptide-1 agonists as potential neuroprotective agents[J].中国神经再生研究（英文版）,2019,14(5):745-748,4.
